M&As this week: Sichuan Kelun Pharma, CiToxLAB

10th November 2016 (Last Updated November 10th, 2016 18:30)

Sichuan Kelun Pharma has announced its intention to acquire stakes in two pharmaceutical companies, one based in Guangxi and another in Changshu.

Sichuan Kelun Pharma has announced its intention to acquire stakes in two pharmaceutical companies, one based in Guangxi and another in Changshu.

"It will acquire the remaining 20% stake in the Guangxi-based company for $5.3m to obtain 100% ownership, and 35% in the Changshu-based biopharmaceutical company."

It will acquire the remaining 20% stake in the Guangxi-based company for $5.3m to obtain 100% ownership, and 35% in the Changshu-based biopharmaceutical company.

French pre-clinical services provider CiToxLAB Group has completed the acquisition of Canadian company, AccelLAB, with the aim of strengthening its position in the non-clinical contract research market and extending its services portfolio to medical devices.

The target company is a pre-clinical contract research organisation that employs approximately 100 people.

CiToxLab operates in France, Canada, Hungary and Denmark with a total of 1,000 staff as a result of the acquisition.